Obsessive-Compulsive Disorder
From the Journals
Therapeutic homework adherence improves tics in Tourette’s disorder
After eight sessions of behavior therapy, overall greater homework adherence significantly predicted reduced tic severity.
From the Journals
Gut health ‘vitally important’ for mental health
“It’s clear that clinicians need to place a greater awareness of gut health when considering the treatment of certain psychiatric disorders.”
Feature
Toward ‘superhuman cognition’: The future of brain-computer interfaces
Among the big players in this area of research is billionaire entrepreneur Elon Musk, who in 2016 founded Neuralink.
Conference Coverage
Neuropsychiatry affects pediatric OCD treatment
The new model of treating OCD revolves around inhibitory learning theory, which focuses on the variability of distress and aims to increase...
From the Journals
Early data for experimental THC drug ‘promising’ for Tourette’s
"We conducted an uncontrolled study in adults with severe TS and found that their tics improved over time while they took THX-110."
Feature
Psychiatric genomics has a diversity problem
For a long time researchers thought including “multiple ancestries in first rounds of genetic analyses” was too complicated, said Dr. Laramie...
Feature
Health anxiety common as COVID restrictions loosen
“There are still people out there not wanting to leave home,” said Reese Druckenmiller of the Mayo Clinic Health System.
Feature
APA, AMA, others move to stop insurer from overturning mental health claims ruling
The APA hopes that whatever the court says about United Behavioral Health applies to all insurers that provide employer-sponsored health benefits...
From the Journals
Tic disorders proliferate in bipolar patients with OCD
Identifying these additional comorbidities, particularly in patients with bipolar depression, might help with management.
Commentary
Let’s not criticize off-label prescribing
It is important to state clearly that off-label prescribing is part and parcel of the good practice of clinical medicine, say Dr. Robert S. Emmons...
From the Journals
Antidepressant may help COVID-19 patients avoid serious illness
Racetrack workers who developed COVID-19 and took a 2-week course of fluvoxamine did not have to be hospitalized and felt better after 2 weeks.